Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04472065 · ClinicalTrials.gov registry record · NA
Study of Probiotic Use After Childbirth in Relation to Emotional Well-Being
A NA study, sponsored by Elizabeth Austen Lawson.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT04472065: Completed NA study, sponsored by Elizabeth Austen Lawson.
NCT04472065 is a NA study that has completed, run by Elizabeth Austen Lawson. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04472065, a NA study, has completed, sponsored by Elizabeth Austen Lawson.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
Researchers at Massachusetts General Hospital are interested in learning more about the neurobiology of well-being in new mothers and novel ways to support them during their transition to parenthood. This study aims to evaluate well-being in new mothers and their infant and the impact of a probiotic dietary supplement on the gut microbiome. This study hopes to help improve the existing knowledge of maternal postnatal health.
Primary Outcome
Mother-infant bonding: Quantitative observational assessment of mother-infant bonding using the Child Interactive Behavior (CIB).
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Lactobacillus reuteri
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-03-10 |
| Est. Completion | 2023-10-16 |
| Phase | NA |
What the finished NCT04472065 record still lists
NCT04472065 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04472065 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04472065 about?
NCT04472065 is a clinical study titled "Study of Probiotic Use After Childbirth in Relation to Emotional Well-Being". Researchers at Massachusetts General Hospital are interested in learning more about the neurobiology of well-being in new mothers and novel ways to support them during their transition to parenthood. This study aims to evaluate well-being in new mothers and their infant and the impact of a probiotic...
What is the current status of trial NCT04472065?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2021-03-10. Estimated completion is 2023-10-16.
What interventions are being tested in trial NCT04472065?
The interventions under investigation include: Placebo (OTHER), Lactobacillus reuteri (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04472065?
This trial is sponsored by Elizabeth Austen Lawson, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04472065's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI